Diabetes Board decisions

The Veteran withdrew his appeal for an increased rating for diabetes mellitus before the Board could make a decision.

The Board has remanded the Veteran's claims for additional development to obtain his service treatment records from July 2001 to December 2001, as these records are necessary to determine if new and material evidence has been submitted to reopen his service connection claims.

The Board has remanded the claims for service connection due to inadequate etiological opinions in the November 2019 VA examinations. Further medical development is required.

The Veteran's claims for residuals of right perforated tympanic membrane, bilateral hearing loss disability, PTSD, diabetes mellitus, and peripheral neuropathies are all denied as there is no evidence to support the presence of these conditions in service or a direct relationship to service.,ED was also denied due to lack of evidence supporting its connection to service.

The Board has remanded the case due to inconsistencies in the VA examination and the need for a supplemental opinion regarding the Veteran's eye conditions, including whether they are related to his service-connected diabetic retinopathy.

The Veteran's claim for an effective date of October 7, 2002 for PTSD service connection is granted. The claims for new and material evidence for diabetes mellitus, increased disability rating for PTSD, service connection for diabetes mellitus secondary to herbicide agent exposure, service connection for cataracts secondary to diabetes mellitus, and service connection for residuals of Agent Orange exposure are remanded.

The Board has remanded the Veteran's claims for bilateral upper and lower neuropathy, diabetes mellitus, and heart disease due to additional development being required. The Veteran must provide more information about specific documents he believes exist in order for VA to attempt to obtain them.

The Veteran's hearing loss and service-connected conditions have been remanded for further development.,The Veteran is seeking increased evaluations for his service-connected disabilities, including hearing loss and coronary artery disease.

The Veteran's claim for an increased rating for diabetes mellitus was denied. Separate ratings of 10 percent were granted for right and left lower extremity femoral nerve diabetic peripheral neuropathy from December 28, 2019.

The Board has remanded the claims of service connection for diabetes mellitus, bilateral upper and lower extremity neuropathy, and erectile dysfunction due to exposure to herbicide agents during reserve duty.

The Veteran's service connection claims for prostate cancer, type II diabetes mellitus, and peripheral neuropathy of the bilateral lower extremities are granted. The claim for glaucoma secondary to diabetes mellitus is remanded.

The Board denied service connection for diabetes mellitus, low back disorder, and hypertension. Service connection was granted for erectile dysfunction (ED) as secondary to the Veteran's service-connected diabetes.,Diabetes, low back disorder, and hypertension were not shown during or within one year after service.

The Board denied the Veteran's claim for service connection for type 2 diabetes mellitus, finding that there was no evidence of a direct relationship between his active duty service and his current condition. The Board also found that prescribed prednisone did not cause or aggravate his diabetes.

The Board has ordered remand for further development on several service connection claims, including joint pain in the hands and feet, skin disorder to the feet, diabetes mellitus, and hypertension. The issues remain on appeal.

The Board has granted service connection for pancreatic cancer as secondary to the Veteran's service-connected diabetes mellitus, resolving reasonable doubt in favor of the appellant.

The Veteran was granted a Total Disability Rating Based on Individual Unemployability (TDIU) effective November 28, 2007. The Board found that the Veteran's service-connected disabilities rendered him unemployable beginning February 8, 2006.

The Board has dismissed the appeals for service connection of ischemic heart disease, chronic kidney disease, type II diabetes mellitus, and prostate cancer as the appellant died during the appeal process.

The Veteran's claim for service connection for diabetes mellitus was denied due to lack of evidence showing in-service incurrence or aggravation.,Service connection for tinnitus is denied as the preponderance of evidence does not support a finding that it began during active duty or is related to noise exposure.,Service connection for a neck disorder is denied as there is no evidence linking the condition to service, and the Veteran's current diagnosis is attributed to natural aging process rather than in-service injury.,Service connection for hypertension is denied due to lack of evidence showing in-service incurrence or aggravation.,Service connection for a right knee disorder is denied as there is no evidence showing it began during active duty or is related to noise exposure.,Service connection for left knee disability is granted with a 20% rating effective from November 14, 2016.,Service connection for lumbar spine disability is denied due to lack of evidence showing in-service incurrence or aggravation.,Service connection for radiculopathy of the left lower extremity is granted with a 10% rating effective from June 11, 2018.,Service connection for radiculopathy of the right lower extremity is denied as there is no evidence showing it began during active duty or is related to noise exposure.,Service connection for somatic symptom disorder with predominant pain is granted with a rating in excess of 70% effective from November 14, 2016.

The Board has remanded the claims for service connection due to new evidence submitted by the Veteran, and requests that an addendum opinion be provided regarding the baseline level of disability prior to aggravation.

An effective date of March 3, 2015, for a 60 percent rating for coronary artery disease (CAD) is granted.,A 100 percent rating as of June 14, 2017, but no earlier, for CAD is granted.,An effective date of June 14, 2017, but no earlier, for the grant of special monthly compensation (SMC) at the housebound rate is granted.,A rating higher than 70 percent for PTSD for accrued benefits is denied.,A rating higher than 20 percent for diabetes mellitus type II (DMII), with erectile dysfunction, for accrued benefits is denied.,Rating higher than 30 percent prior to August 9, 2019, and higher than 60 percent thereafter for diabetic nephropathy with hypertension for accrued benefits is denied.